A new survey of the serology of human Trypanosoma cruzi infection in the Rio Negro microregion, Brazilian Amazon: a critical analysis

Similar documents
Surveillance, health promotion and control of Chagas disease in the Amazon Region - Medical attention in the Brazilian Amazon Region: a proposal

The Application of Latent Class Analysis for Diagnostic Test Validation of Chronic Trypanosoma cruzi Infection in Blood Donors

Criteria of Chagas Disease Cure

Prevalence of Trypanosoma cruzi infection among Bolivian immigrants in the city of São Paulo, Brazil

Chagas disease: what is known and what is needed A background article

Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon

Leishmania (Viannia) naiffi: rare enough to be neglected?

Emerging Acute Chagas Disease in Amazonian Brazil: Case Reports With Serious Cardiac Involvement

Epidemiology, Biochemistry and Evolution of Trypanosoma cruzi Lineages Based on Ribosomal RNA Sequences

Seroprevalence of Trypanosoma cruzi Infection in Students at the Seven-Fourteen Age Range, Londrina, PR, Brazil, in 1995

Variations of the External Male Genitalia in Three Populations of Triatoma infestans Klug, 1834

Key words: malaria - Plasmodium vivax - merozoite antigens - IgG antibody response MATERIALS AND METHODS

PROPORTIONAL MORTALITY RATIO DUE TO CHAGAS DISEASE IS FIVE TIMES HIGHER FOR THE STATE OF GOIAS THAN THE REST OF BRAZIL

International Journal of Environmental & Agriculture Research (IJOEAR) ISSN:[ ] [Vol-3, Issue-4, April- 2017]

Serodiagnosis of Trypanosoma cruzi Infection Using the New Particle Gel Immunoassay - ID-PaGIA Chagas

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

Received 24 March 2003/Returned for modification 1 May 2003/Accepted 8 July 2003

Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries

Subclinical Form of the American Visceral Leishmaniasis

Mapping cancer, cardiovascular and malaria research in Brazil

Elimination of Chagas disease transmission: perspectives

Evaluation of Three Commercial Enzyme-Linked Immunosorbent Assays for Diagnosis of Chagas Disease

KEY WORDS: Chagas disease; blood donors; visceral leishmaniasis; cross reactivity.

Safety of benznidazole use in the treatment of chronic Chagas disease

Malaria Control in an Agro-industrial Settlement of Rondônia (Western Amazon Region, Brazil)

Variability of Kinetoplast DNA Gene Signatures of Trypanosoma cruzi II Strains from Patients with Different Clinical Forms of Chagas Disease in Brazil

DETECTION AND SIGNIFICANCE OF INAPPARENT INFECTION IN CHAGAS DISEASE IN WESTERN VENEZUELA

Trypanosoma cruzi Parasitemia in US Blood Donors with Serologic Evidence of Infection

Chagas disease: Challenges in Diagnostics

Luiz Herman Soares Gil/ +, Mauro Shugiro Tada/*, Tony Hiroshi Katsuragawa*, Paulo Eduardo Martins Ribolla**, Luiz Hildebrando Pereira da Silva/*

ABSTRACT. Contents available at PubMed Rev Inves Clin. 2016;68: BRIEF COMMUNICATION

Tuberculosis surveillance and health information system in Brazil,

Camila Aguiar, Angelica M. Batista, Tycha B. S. Pavan, Eros A. Almeida, Maria E. Guariento, Jamiro S. Wanderley and Sandra C. B.

Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection

Carlos José de Carvalho Moreira +, Maria Celeste Dias Spata

Chagas disease. (American trypanosomiasis)

Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study

Comparison of light microscopy and nested PCR assay in detecting of malaria mixed species infections in an endemic area of Iran

Morphobiological aspects of Rhodnius brethesi

(Paludism) .(and Gilles (Plasmodium). (Anopheles) . Nested-PCR. Downloaded from sjsph.tums.ac.ir at 12:13 IRST on Monday March 11th 2019

Field evaluation of a rapid immunochromatographic assay for ACCEPTED

Congenital transmission of Trypanosoma cruzi in central Brazil. A study of 1,211 individuals born to infected mothers

Infestation of peridomestic Attalea phalerata palms by Rhodnius stali, a vector of Trypanosoma cruzi in the Alto Beni, Bolivia

Update on Chagas Disease in Venezuela A Review

Higher risk for myelopathy development among HTLV-I / HIV-I coinfected subjects

Trypanosoma cruzi in Persons without Serologic Evidence of Disease, Argentina

Prevalence of Hepatitis B and C Virus Markers among Malaria-exposed Gold Miners in Brazilian Amazon

Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay

Trypanosomiasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre

Chagas Ab. Principle of the Test. Introduction. Figure 1. Principle of the Test

Spatiotemporal analysis of reported cases of acute Chagas disease in the State of Pernambuco, Brazil, from 2002 to 2013

Received: 11 June 2008 Accepted: 8 July 2008

Prevalence of hepatitis C virus genotypes in the State of Pará, Brazil

Chagas Disease in non-endemic Countries

Serological Markers of Hepatitis A, B and C Viruses in Rural Communities of the Semiarid Brazilian Northeast

A Follow-Up Study of Chagasic Patients with Special Reference totrypanosoma cruzi Persistence and Criteria of Chagas Disease Cure

Cerebrospinal Fluid in CNS Infections

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction

Molecular and Biochemical Parasitology, 16 (1985) Elsevier MBP 00580

Urban transmission of Chagas disease in Cochabamba, Bolivia

TcI/TcII co-infection can enhance Trypanosoma cruzi growth in Rhodnius prolixus

Combined Use of Enzyme-Linked Immunosorbent Assay and Flow Cytometry To Detect Antibodies to Trypanosoma cruzi in Domestic Canines in Texas

Evaluation of rk28 antigen for serodiagnosis of visceral Leishmaniasis in India


Zincum metallicum controls tissue inflammation in mice infected by Trypanosoma cruzi

Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet

Genitourinary Changes in Hamsters Infected and Reinfected with Trypanosoma cruzi

Comparison of conventional serology and PCR methods for the routine diagnosis of Trypanosoma cruzi infection

Lesion aspirate culture for the diagnosis and isolation of Leishmania spp. from patients with cutaneous leishmaniasis

Molecular diagnosis of cutaneous leishmaniasis in an endemic area of Acre State in the Amazonian Region of Brazil

Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance

HOUSEHOLD RISK FACTORS FOR TRYPANOSOMA CRUZI SEROPOSITIVITY IN TWO GEOGRAPHIC REGIONS OF ECUADOR

BJID 2004; 8 (April)

Responding to HIV & ZIKA in Brazil

A polymerase chain reaction-based assay to identify genotype F of hepatitis B virus

Experimental benznidazole treatment of Trypanosoma cruzi

Convención Internacional de Salud, Cuba Salud 2018

Title:Evaluating HBsAg rapid tests performance in different biological samples from low- and high infection rates settings & populations

Seroepidemiological aspects of human infection by Strongyloides stercoralis in Alfenas, southern Minas Gerais, Brazil

Izilda Curado/ +, Ana Maria RC Duarte*, Altaf A Lal**, Salma G Oliveira***, Judith K Kloetzel*/****

Isis Fernandes Magalhães-Santos, Márcia Maria Souza, Carolina Silva Costa Lima, Sonia G Andrade +

Pacemaker Implants in Children and Adolescents with Chagas Disease in Brazil: 18-Year Incidence

Charlotte L. Kerr 1, Tapan Bhattacharyya 1*, Samanta C. C. Xavier 2, Juliana H. Barros 2, Valdirene S. Lima 2, Ana M. Jansen 2 and Michael A.

Prevalent opportunistic infections associated with HIV-positive children 0-5 years in Benin city, Nigeria

Paracoccidioidomycosis associated with human immunodeficiency virus infection

WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Antoniana Ursine Krettli. Instituto de Pesquisas René Rachou-Fiocruz, Av. Augusto de Lima 1715, Belo Horizonte, MG, Brasil

Key words: Trypanosoma cruzi, genetic diversity, biological diversity

New records of Mansonella ozzardi

Antiparasitic activity of risedronate in a murine model of acute Chagas disease

Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the symptomatic vs asymptomatic dichotomy

Laboratory diagnosis of congenital infections

Chagas Disease: Current Epidemiological Trends after the Interruption of Vectorial and Transfusional Transmission in the Southern Cone Countries

Chagas Disease in the Americas: Impacts and Opportunities for Control

Information Level, Risk Perception And HIV/AIDS Socio- Cultural Aspects Relation In Young People Of Itabuna, Northeast, Brazil.

PREDICTIVE VALUE OF LATEX AGGLUTINATION TEST IN SEROLOGICAL SCREENING FOR TOXOPLASMA GONDII

Trypanosoma cruzi in the Anal Glands of Urban Opossums. I- Isolation and Experimental Infections

Frequency of the HFE C282Y and H63D polymorphisms in Brazilian malaria patients and blood donors from the Amazon region

Transcription:

Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 108(7): 909-913, November 2013 909 A new survey of the serology of human Trypanosoma cruzi infection in the Rio Negro microregion, Brazilian Amazon: a critical analysis José Rodrigues Coura 1 / +, Maurício Humberto Peña Marquez 2, Jorge Augusto de Oliveira Guerra 2, Patricia Lago Zauza 1, Julio Cesar Miguel 1, José Borges Pereira 1 1 Laboratório de Doenças Parasitárias, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brasil 2 Instituto de Medicina Tropical do Amazonas Heitor Vieira Dourado, Manaus, AM, Brasil The serology of human Trypanosoma cruzi infection in the Rio Negro microregion is very complex because of the large numbers of false-positive cases that result from low antibody titres and cross-reactions with other infections. In the present study, we collected 4,880 blood samples on filter paper; of these, indirect immunofluorescence (IIF) was strongly reactive in 221 (4.5%), which were considered to be positive (IIF strongly reactive; high intensity of fluorescence) and weakly reactive in 302 (6.2%), which were considered to be doubtful (IIF weakly reactive; low intensity of fluorescence). The confirmatory test on the serum using at least two of three techniques (IIF, conventional ELISA and recombinant ELISA) on 137 samples that were positive in the screening test only confirmed 33 cases (24.1%). Of the 178 samples that were considered doubtful in the screening test, only 10 (5.6%) were considered to be positive in the confirmatory test. Finally, we recommend that the serological diagnosis of T. cruzi infection in the Amazon region be made using at least two different techniques, for example immunofluorescence and ELISA and confirmed by Western blot analysis when possible. Key words: Trypanosoma cruzi - human infection - serology - Brazilian Amazon Previously, between 1991-1997, we conducted three serological surveys of human Trypanosoma cruzi infection in the main settlement of the municipality of Barcelos, in the Rio Negro microregion, state of Amazonas (AM) (Coura et al. 1995a, b, 1999, 2002a, b). In the first serological survey (1991), in which 710 indirect immunofluorescence (IIF) tests were performed on blood collected on filter paper, 89 (12.5%) were positive. In the second survey conducted using the same technique in 1993, 90 of the 658 total samples (13.7%) were also positive. Finally, in the third survey in 1997, of the 886 serum samples analysed using the Diamed ID-PaGIA agglutination test, 117 (13.2%) were reactive. Therefore, of the 2,254 tests performed, the average positivity rate was 13.1%, which seemed to be high based on epidemiological conditions of the region (Table I). When we showed a collection of triatomines of the genera Triatoma, Panstrogylus and Rhodnius to a group of patients who we interviewed, 206 (20.7%) recognised the insects as piassava lice, as these triatomines are known in their region. Among the patients who recognised the triatomines, 139 (67.5%) were harvesters of piassava fibre in the rural zone of Barcelos, their workplace and 62 (30%) said that they had already been bitten by this insect in their huts in the piassava plantations. doi: 10.1590/0074-0276130303 Financial support: CNPq (471716/2009-0) + Corresponding author: coura@ioc.fiocruz.br Received 5 June 2013 Accepted 16 August 2013 Among the individuals who reported previous attacks by triatomines, 25.8% presented antibodies for T. cruzi infection, while 11.7% of the individuals who had never been bitten also revealed positive serological results (p = 0.03) (Fig. 1). When we used the IIF test on serum with conventional and recombinant ELISA and Western blot (TESA-blot) as confirmatory tests, we were only able to confirm 2.8-5% of the tests as positive. As a result of this previous study and due to our greater experience with Chagas disease in the area (Coura et al. 2002b, Albajar et al. 2003, Junqueira et al. 2005, Xavier et al. 2006, Brum-Soares et al. 2010), we decided in 2010 to conduct a new and larger serological survey in this area to correct certain technical interpretations regarding the previous serological surveys, including those related to immunofluorescence. For unknown reasons, intense immunofluorescence is frequently observed on the parasite s body in this region or at some points of its membrane, sometimes interpreted erroneously as positive when this staining is actually a false-positive. This staining led to the high prevalence of positivity (13.1%) in the first screening surveys. In contrast, Diamed ID-PaGIA was shown to have low specificity in the study area. SUBJECTS, MATERIALS AND METHODS Location of the study area - The administrative district of Barcelos is located north of AM. To the east, it borders the state of Roraima; to the southeast and south, it borders the district of Santa Isabel do Rio Negro and, to the north, it borders Venezuela (latitude 0 58 1 south of the equator and longitude 62 56 west of Greenwich). The city of Barcelos, where this study was conducted, is located on the right bank of the Negro River, 490 km from Manaus, the capital of AM (Fig. 2). online memorias.ioc.fiocruz.br

910 Serology of T. cruzi human infection José Rodrigues Coura et al. TABLE I Seroprevalence for Trypanosoma cruzi infection in Barcelos, state of Amazonas, Brazil, by indirect immunofluorescence (IIF) from filter paper and serum for Diamed ID-PaGIA agglutination test Seroprevalence (screening tests a ) Age group (years) Tested/positive 1991 (IIF) 1993 (IIF) 1997 (ID-PaGIA) 0-10 197 (7.6) 248 (5.6) 215 (12.1) 11-20 208 (11.7) 143 (13.3) 255 (25.4) 21-30 91 (14.3 ) 91 (9.9) 139 (15.7) 31-40 76 (19.7) 58 (8.6) 100 (11.3) 41-50 58 (12.1) 42 (7.1) 69 (7.8) 51-60 34 (8.8) 34 (11.8) 43 (4.9) > 60 46 (22.2) 42 (24) 65 (7.4) Total 710 (12.5 ) 658 (13.7) 886 (13.2) a: only 2.8-5% confirmed by IIF, ELISA and/or recombinant ELISA and Western blot. Source: Coura et al. (1999). Fig. 1: percentage of seropositives in persons bitten and non bitten by triatomines in Barcelos, state of Amazonas, Brazil, 1997. Survey and samples - The new serological survey was conducted in the main settlement of Barcelos and covered the entire resident population that was willing to participate in the survey after providing informed consent. For minors, the informed consent was provided by their parents or guardians. The main settlement of the municipality was divided into six areas (A-F), which were to be covered by the municipality s health agents under supervision by two laboratory technicians at the municipal hospital. The teams were trained by the project coordinator (JR Coura, a physician and infectologist) and were monitored throughout the survey by a postgraduate student (MHP Marquez). Each team was composed of two health agents; the two laboratory technicians each supervised three of the teams and all six teams were monitored by the postgraduate student. In total, 4,880 blood samples were collected on filter paper in accordance with the technique of Souza and Camargo (1966) for the screening test: 770 samples were collected by team A (São Sebastião), 925 by team B (São Lázaro), 1,000 by team C (São Francisco), 728 by team D (Nazaré), 817 by team E (Vila Linhares) and 640 by team F (Aparecida). All the blood samples on the filter paper were eluted in 250 µl of phosphate-buffered saline (ph 7.2) and were tested using the IIF test, as recommended by Fife and Muschel (1959) and Souza and Camargo (1966), as adapted by Ostermayer et al. (2011) for the detection of anti-t. cruzi antibodies. The IIF-Chagas kit produced by Biomanguinhos was used. In this kit, the antigens used are cultured epimastigote forms of T. cruzi in liver infusion tryptose medium. The tests were performed in the serology sector of the Parasitic Diseases Laboratory of the Oswaldo Cruz Institute, Oswaldo Cruz Foundation, state of Rio de Janeiro (RJ), Brazil. The slides were prepared in accordance with the classical techniques for IIF and were examined under an immunofluorescence microscope by at least two observers. The slide readings were considered to be negative (unreactive, absence of fluorescence), doubtful (weakly reactive, low intensity of fluorescence) or positive (strongly reactive, high intensity of fluorescence). Confirmatory serological test - To perform confirmatory reactions, venous blood (5 ml) was collected by the laboratory technicians from 315 patients (60%) who presented positive (137 patients; 62%) or doubtful (178 patients; 59%) IIF reactions to T. cruzi infection based on the serological screening of blood on the filter paper. After separation, the serum was frozen, packed on dry ice and sent from Barcelos to our laboratory in RJ. These serum samples were subjected to three serological reactions: IIF (Chagas kit, Biomanguinhos) with a dilution of 1:40, with the positive samples tittered as much as 1:1,280, conventional ELISA (DMED kit) and recombinant ELISA (Wiener Lab. V.3.0 kit). Samples were considered to be seronegative if two or three of the tests were negative and seropositive if two or three of the tests were positive. Samples that presented only one positive test were considered to be divergent. RESULTS Serological screening test - The screening test performed on the blood placed on the filter paper using immunofluorescence, 221 (4.5%) of the 4,880 samples were considered to be positive (strongly reactive) and 302 (6.2%) were considered to be doubtful (weakly positive) (Table II). Of the 4,880 samples examined, 2,741 (56.2%) were from females and 2,139 (43.8%) were from males. Among the 221 samples that were considered to be positive, 104 (3.8%) were from females and 117 (5.5%) were from males. The numbers of blood samples collected on filter paper, along with the percentage of positivity

Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 108(7), November 2013 911 Fig. 2: location of Barcelos, state of Amazonas, Brazil, 2010, and number of blood samples collected by teams (A-F) and city district for screen tests. TABLE II Screening tests for Trypanosoma cruzi infection by indirect immunofluorescence (IIF) in 4,880 blood samples from filter paper Age groups (years) Tested n Positives Doubtful < 5 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-69 70-79 > 79 Unknown a a: Yanomami Indians. 495 626 622 524 872 578 413 293 227 138 55 37 9 (1.8) 18 (1.9) 12 (2.9) 24 (4.6) 46 (5.3) 34 (5.9) 24 (5.8) 19 (6.5) 17 (7.5) 9(6.5) 4 (7.3) 5 (13.5) 17 (3.4) 30 (4.8) 30 (4.8) 35 (6.7) 56 (6.4) 41 (7.1) 39 (9.4) 18 (6.1) 17 (7.5) 10 (7.2) 2 (3.6) 7 (18.9) 4,880 221 (4.5) 302 (6.2) for T. cruzi infection, varied according to the number of people living in the area and their degree of exposure to infection in rural areas, especially in relation to piassava harvesters and their families. This characteristic has already been presented in previous studies by our group (Coura et al. 1995a, b, 2002a, b, 1999, Albajar et al. 2003a, b, Junqueira et al. 2005, Xavier et al. 2006, Brum-Soares et al. 2010, Coura & Junqueira 2012, Junqueira et al. 2013). The prevalence of serological positivity in samples collected on filter paper gradually increased after the age of 15 years, precisely when adolescents (especially males) started to be involved in piassava harvesting and after the age of 20 years among women, when as Fig. 3: percentage of positive immunefluorescence by age group in the screen tests in Barcelos, state of Amazonas, Brazil, 2010. wives would accompany their husbands to the piassava plantations (Fig. 3, Table II). The unknown age group (Yanomami Indians who do not know their age) is the most exposed to wild triatomines in the forest; therefore, they had the highest percentage of IIF-positive results (13.5%), as shown in Fig. 3. Confirmatory serological test - Among the 137 serum samples that were considered to be positive based on immunofluorescence testing, 37 (27%) were considered to be seronegative based on the confirmatory serological test, 67 (48.9%) were considered to be serodivergent, as only one of the three reactions was positive, and only 33 (24.1%) were confirmed as seropositive, with two or three positive reactions (Table III). Of the 178 serum samples for which the immunofluorescence was considered doubtful, 89 (50%) were seronegative in all three confirmatory reactions, 79 (44.4%) were considered to be serodivergent, with only one positive reaction out of the three reactions, and only 10 (5.6%) were considered to be seropositive, with two or three positive reactions (Table III). In summary, of the 137 samples that were positive in the screening serological tests, only 33

912 Serology of T. cruzi human infection José Rodrigues Coura et al. TABLE III Confirmatory serological tests of 137 samples positives and 178 doubtful by indirect immunofluorescence (IIF) in blood from filter paper evaluated by IIF and ELISA conventional and or recombinant Serological evaluation Seronegatives Serodivergents Seropositives Positives IIF from filter paper 37 (27) 67 (48.9) 33 (24.1) Doubtful IIF from filter paper 89 (50) 79 (44.4) 10 (5.6) Total 137 (100) 178 (100) Fig. 4: titres of IgG of immunofluorescence in serum from confirmatory serological tests in Barcelos, state of Amazonas, Brazil, 2011. IIF: indirect immunofluorescence. (24.1%) were positive in the confirmatory tests, while only 10 (5.6%) of the 178 samples that were doubtful in the screening test were positive in the confirmatory test, as shown in Table III. The numbers of serum samples and the titres of IgG confirmed by immunofluorescence as positive are shown in Fig. 4. These data most likely reflect the low level of parasitaemia and the particular T. cruzi strain circulating in the area (TcI), which likely provide low stimulation for antibody genesis. DISCUSSION The high prevalence found in the preliminary serological screening surveys that we conducted in 1991, 1993 and 1997 (Coura et al. 1999) certainly occurred due to cross-reactions with a variety of diseases that are endemic in this area, including malaria, American cutaneous leishmaniasis, tuberculosis, leprosy and Trypanosoma rangeli infection. Additionally, the low titres of anti-t. cruzi antibodies demonstrated in the present study favoured occurrences of cross-reactions with other infections. The prevalence of T. cruzi infection in Barcelos was observed to vary according to the intensity of exposure. In a group of 244 highly exposed individuals, we found that 11% were serologically positive (IIF and TESA-blot). However, among the 46 individuals in this group who underwent xenodiagnosis and polymerase chain reaction (PCR) analysis, we only isolated T. cruzi in 19% of the individuals through xenodiagnosis and the PCR was only positive in these cases (Coura et al. 1999), thus demonstrating that the parasitaemia is low in this region. Fernandes et al. (1998a, b) demonstrated only two lineages of T. cruzi in the area (TcI and Z3). Although no studies have provided evidence, we can suppose that these lineages of T. cruzi are poorly immunogenic for antibody generation. Finally, we recommend that the serological diagnosis of T. cruzi infection in the Amazon Region should be made using at least two different techniques, e.g., immunofluorescence and ELISA and confirmed by Western blot analysis when possible. ACKNOWLEDGEMENTS To Eloisa Diniz, for producing the Figs 1-4. REFERENCES Albajar PV, Laredo SV, Terrazas MB, Coura JR 2003. Miocardiopatia dilatada em pacientes com infecção chagásica crônica. Relato de dois casos fatais autóctones do Rio Negro, estado do Amazonas. Rev Soc Bras Med Trop 36: 401-407. Brum-Soares LM, Xavier SS, Sousa AS, Pereira JB, Ferreira JMBB, Costa IR, Junqueira ACV, Coura JR 2010. Morbidade da doença de Chagas em pacientes autóctones da microrregião do Rio Negro, estado do Amazonas. Rev Soc Med Trop 43: 170-177. Coura JR, Arboleda Naranjo M, Willcox HPF 1995a. Chagas disease in the Brazilian Amazon. II. A serological survey. Rev Inst Med Trop São Paulo 37: 103-107. Coura JR, Junqueira ACV 2012. Risks of endemicity, morbidity and perspectives regarding the control of Chagas disease in the Amazon Region. Mem Inst Oswaldo Cruz 107: 145-154. Coura JR, Junqueira ACV, Boia MN, Fernandes O 1999. Chagas disease: from bush to huts and houses. Is it the case of the Brazilian Amazon? Mem Inst Oswaldo Cruz 94 (Suppl. I): 379-384. Coura JR, Junqueira ACV, Boia MN, Fernandes O, Bonfante C, Campos JE, Santos L, Devera R 2002a. Chagas disease in the Brazilian Amazon. IV. A new cross sectional study. Rev Inst Med Trop São Paulo 44: 159-165. Coura JR, Junqueira ACV, Fernandes O, Valente SAS, Miles MA 2002b. Emerging Chagas in Amazonian Brazil. Trends Parasitol 18: 171-176. Coura JR, Willcox HPF, Arboleda Naranjo M, Fernandes O, Paiva DD 1995b. Chagas disease in the Brazilian Amazon. III. A crosssectional study. Rev Inst Med Trop São Paulo 37: 415-420. Fernandes O, Souto RP, Castro JA, Pereira JB, Fernandes NC, Junqueira ACV, Naiff RD, Barret TB, Degrave W, Zingales B, Campbell DA, Coura JR 1998a. Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. Am J Trop Med Hyg 58: 807-811. Fernandes O, Sturm NR, Derre R, Campbell DA 1998b. The miniexon gene: a molecular marker for zymodeme III of Trypanosoma cruzi. Mol Biochem Parasitol 95: 129-133.

Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 108(7), November 2013 913 Fife EH, Muschel LH 1959. Fluorescent antibody technique for serodiagnosis of Trypanosoma cruzi infection. Proc Soc Exp Biol Med 101: 540-543. Junqueira ACV, Albajar PV, Coura JR 2005. Enfermedad de Chagas en la Amazonia brasileña. In Guhl F, Primer taller internacional sobre control de la enfermedad de Chagas, Universidad de los Andes, Bogotá, p. 277-287. Junqueira ACV, Albajar PV, Coura JR 2013. Doença de Chagas na Amazônia brasileira. In JR Coura, Dinâmica das doenças infecciosas e parasitárias, 2nd ed., Guanabara Koogan, Rio de Janeiro, p. 642-648. Ostermayer AL, Passos AD, Silveira AC, Ferreira AW, Macedo V, Prata AR 2011. O inquérito nacional de soroprevalência de avaliação do controle da doença de Chagas no Brasil (2001-2008). Rev Soc Med Trop 44: 108-121. Sousa SL, Camargo ME 1966. The use of filter paper blood smears in a practical fluorescent test for American tripanosomiasis serodiagnosis. Rev Inst Med Trop 8: 255-258. Xavier SS, Sousa AS, Albajar PV, Junqueira ACV, Bóia MN, Coura JR 2006. Cardiopatia chagásica crônica na Amazônia brasileira. Relato de três novos casos autóctones do Rio Negro, estado do Amazonas, comprovados por exames sorológicos, clínicos, radiográficos, eletro e ecocardiográficos. Rev Soc Bras Med Trop 39: 211-216.